PNC FINANCIAL SERVICES GROUP, INC. - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 35 filers reported holding ONCOCYTE CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$2,300
-35.0%
10,0000.0%0.00%
Q1 2023$3,540
+10.3%
10,0000.0%0.00%
Q4 2022$3,210
-54.1%
10,0000.0%0.00%
Q3 2022$7,000
-22.2%
10,0000.0%0.00%
Q2 2022$9,000
-40.0%
10,0000.0%0.00%
Q1 2022$15,000
+1400.0%
10,000
+3211.3%
0.00%
Q3 2021$1,000302
+2057.1%
0.00%
Q2 2020$0140.0%0.00%
Q1 2020$0140.0%0.00%
Q4 2019$0140.0%0.00%
Q3 2019$0140.0%0.00%
Q2 2019$0140.0%0.00%
Q1 2019$0140.0%0.00%
Q4 2018$0140.0%0.00%
Q3 2018$0140.0%0.00%
Q2 2018$0140.0%0.00%
Q1 2018$0140.0%0.00%
Q4 2017$0140.0%0.00%
Q3 2017$0140.0%0.00%
Q2 2017$0
-100.0%
14
-99.7%
0.00%
Q1 2017$24,000
-14.3%
4,0140.0%0.00%
Q4 2016$28,000
+40.0%
4,0140.0%0.00%
Q3 2016$20,000
+42.9%
4,0140.0%0.00%
Q2 2016$14,000
-22.2%
4,0140.0%0.00%
Q1 2016$18,0004,0140.00%
Other shareholders
ONCOCYTE CORP shareholders Q2 2016
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,596,680$16,725,0002.33%
Artal Group S.A. 150,000$698,0000.01%
Destination Wealth Management 29,656$138,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 145,000$674,0000.01%
IHT Wealth Management, LLC 563$2,0000.00%
WELLS FARGO & COMPANY/MN 695$3,0000.00%
NORTHERN TRUST CORP 44,048$205,0000.00%
Vantage Investment Advisors, LLC 25$00.00%
UBS Group AG 5,204$24,0000.00%
Legal & General Group Plc 384$2,0000.00%
View complete list of ONCOCYTE CORP shareholders